The Synthetic Biology Project provides independent, rigorous analysis that can inform critical decisions affecting the research, commercialization and use of synthetic biology. Its objective is to help ensure that, as synthetic biology moves forward, possible risks are minimized and benefits maximized.
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter.” Subscribe to the BIO Newsletter.
Synthetic biology combines molecular biology and systems biology with engineering principles to design biological systems and bio-factories. The aim is to create improved biological functions to address current and future challenges. We believe synthetic biology will change the way we create energy, produce food, optimize industrial processing, and detect, prevent, and cure disease. We are committed to offering unparalleled technology and solutions to this research community. Through science and engineering, this unique area enables researchers to study, alter, create, and re-create highly complex pathways, DNA sequences, genes, and natural biological systems, in order to understand and answer some of life’s most challenging questions.